Creative Planning
SKBI

Creative Planning’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Creative Planning’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,000
Closed -$20K – 3961
2015
Q1 		$20K Hold
5,000
– – ﹤0.01% 2737
2014
Q4 		$21K Buy
+5,000
New +$21.6K ﹤0.01% 2629

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

Creative Planning's SKBI Position: Q2 2015 in Review

Creative Planning sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q2 2015, closing a stake of 5,000 shares — an estimated $20K sold.

Creative Planning first reported a position in SKBI in Q4 2014 and held it in 2 quarters. The position peaked at $21K in Q4 2014. 15 funds tracked by Wall St. Rank hold SKBI as of Q2 2015.

  • Creative Planning reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q2 2015 after selling out during the quarter.
  • Creative Planning sold 5,000 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q2 2015, an estimated $20K.
  • Creative Planning first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q4 2014 and held it in 2 quarters.
  • Creative Planning's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $21K in Q4 2014.
  • 15 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q2 2015.

Based on Creative Planning's 13F filing for Q2 2015, filed 9 Jul 2015.